[Concern about liver disease in children]
Abuduxikuer Kuerbanjiang1, J S Wang1
1Department of Infectious Disease, Children's Hospital of Fudan University, Shanghai 201102, China.
Summary
Pediatric liver disease trends are shifting from viral to hereditary and environmental causes. Early detection and intervention are crucial for children
Area of Science:
- Pediatrics
- Hepatology
- Public Health
Background:
- Shifting landscape of pediatric liver diseases: decreasing viral infections, increasing hereditary, environmental, and lifestyle-related conditions.
- While rare, pediatric liver disease significantly impacts child development, mental well-being, quality of life, and incurs substantial socioeconomic costs.
- The changing epidemiology necessitates a re-evaluation of current diagnostic and management strategies for pediatric liver conditions.
Purpose of the Study:
- To highlight the evolving patterns of liver disease in pediatric populations.
- To emphasize the importance of addressing non-viral liver diseases in children.
- To advocate for enhanced early screening, diagnosis, and treatment protocols for pediatric liver diseases.
Main Methods:
- Review of epidemiological data on pediatric liver disease trends.
- Analysis of the impact of socioeconomic development on disease prevalence.
- Synthesis of current knowledge on the etiology and consequences of pediatric liver diseases.
Main Results:
- A decline in chronic viral liver diseases among children.
- A rise in liver diseases attributed to genetic factors, environmental exposures, and lifestyle choices.
- Recognition of the significant long-term health and economic implications of chronic pediatric liver conditions.
Conclusions:
- Pediatric liver disease requires increased attention beyond viral etiologies.
- Early screening and timely diagnosis are essential for effective management.
- Proactive intervention can mitigate disease progression and improve long-term outcomes for affected children.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
1.6K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.6K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
77
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
77
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
101
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
101
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
89
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
01:24Liver Regeneration
3.9K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.9K
01:28Esophageal Varices-II: Clinical Features and Management
234
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
234